# Membrane-Acting Peptides

> **NIH NIH R15** · THE TRUSTEES OF THE STEVENS INSTITUTE OF TECHNOLOGY · 2020 · $462,600

## Abstract

Membrane-Acting Peptides
Bioactive peptides regulate many physiological processes, acting at some sites as endocrine or paracrine
signals and at others as neurotransmitters or growth factors, have important and positive impacts on human
health including antimicrobial, antifungal, antiviral, and antitumor activities. In this project, we will explore
a new rationale design approach to membrane-acting peptides. We will: 1) design and develop new bioactive
peptides based on on-membrane peptide assembly; 2) study the biological implications of peptides in vitro; 3)
evaluate the pharmaceutical significance of promising peptides on disease cells and co-cultures.

## Key facts

- **NIH application ID:** 10114789
- **Project number:** 1R15GM140421-01
- **Recipient organization:** THE TRUSTEES OF THE STEVENS INSTITUTE OF TECHNOLOGY
- **Principal Investigator:** JUN F LIANG
- **Activity code:** R15 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $462,600
- **Award type:** 1
- **Project period:** 2020-09-15 → 2024-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10114789

## Citation

> US National Institutes of Health, RePORTER application 10114789, Membrane-Acting Peptides (1R15GM140421-01). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10114789. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*